for voiding dysfunctions
6-Month clinical data abstract accepted for Poster Presentation at ICS 2018
14 August 2018
We are pleased to announce that our 6-month clinical data abstract has been accepted for Poster Presentation at the upcoming ICS 2018 Meeting 28-31 August in Philadelphia, USA.
Urolon™ clinical trial: 12-month interim data available
17 July 2018
The Urolon™ European Clinical Trial reaches another milestone; all patients have now completed their 12-month follow-up visit.
Urolon™ has received CE certification!
01 June 2018
We are delighted to announce that Urolon™ has received CE certification! Urolon™ is a safe and effective bioresorbable urethral bulking agent for the treatment of stress urinary incontinence (SUI).
AQLANE Medical™ proudly sponsors ‘Heart for Emergency/Aid Workers’
18 May 2018
Emergency and Aid workers work tirelessly to protect human lives yet aggression and violence against them is on the increase.
Urolon™ clinical trial: 6-month interim data available
07 March 2018
The AQLANE Medical™ European Clinical Trial continues to make progress as subjects reach their 12-month follow-up!